Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Westlake Chemical Partners (WLKP) EBITDA (2016 - 2025)

Historic EBITDA for Westlake Chemical Partners (WLKP) over the last 13 years, with Q3 2025 value amounting to $92.0 million.

  • Westlake Chemical Partners' EBITDA fell 1614.56% to $92.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.8 million, marking a year-over-year decrease of 1773.67%. This contributed to the annual value of $390.4 million for FY2024, which is 915.16% up from last year.
  • According to the latest figures from Q3 2025, Westlake Chemical Partners' EBITDA is $92.0 million, which was down 1614.56% from $91.2 million recorded in Q2 2025.
  • Westlake Chemical Partners' 5-year EBITDA high stood at $140.8 million for Q4 2021, and its period low was $46.6 million during Q1 2025.
  • Moreover, its 5-year median value for EBITDA was $92.0 million (2025), whereas its average is $91.4 million.
  • Its EBITDA has fluctuated over the past 5 years, first surged by 8137.84% in 2021, then tumbled by 5099.31% in 2025.
  • Quarter analysis of 5 years shows Westlake Chemical Partners' EBITDA stood at $140.8 million in 2021, then plummeted by 32.32% to $95.3 million in 2022, then dropped by 2.58% to $92.8 million in 2023, then dropped by 0.85% to $92.0 million in 2024, then dropped by 0.05% to $92.0 million in 2025.
  • Its EBITDA was $92.0 million in Q3 2025, compared to $91.2 million in Q2 2025 and $46.6 million in Q1 2025.